A growing proportion of women diagnosed with breast cancer present with earlier disease stages, and many will relapse and die from their disease. While survival rates are improving with the development of new systemic therapies, there is an urgency to improve treatment outcomes further in early ...
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries[J]. Lancet, 2018, 391(10125): 1023-1075. doi: 10.1016/S0140-6736(17)33326-3 ...
Age-standardized mortality rates forbreast cancer steadily increased d... KY Yoo,Yang 被引量: 0发表: 2003年 Current situation and advancement of Clusterin in breast cancer there are two elusterin isoforms.The nuclear form enhances apoptosis and the secreted form promotes cell survival.Researches ...
85,86], typically fuelled by retrospective studies applying risk factor-based decision rules to cohorts of women that partook in service screening [86,87,88,89]. For example, Lee et al. examined recall rates, cancer detection rates and positive ...
In this brief report, we offer a concise overview on current cancer epidemiology garnered from the official databases of World Health Organization and American Cancer Society and provide recent information on frequency, mortality, and survival expectancy of the 15 leading types of cancers worldwide. ...
(SREs). SREs significantly impact patients' quality of life and reduce survival rates [4,5]. It is worth noting that breast cancer metastasis can have a long dormant period, and some patients may experience recurrence and metastasis, especially bone metastasis, up to 20 years after the ...
Breast cancer (BC) is the most frequently diagnosed cancer in women worldwide with more than 2 million new cases in 2020. Its incidence and death rates have increased over the last three decades due to the change in risk factor profiles, better cancer registration, and cancer detection. The ...
58, 59, 60, 61, 62, 63 The wide range of reported concordance rates between IHC and FISH assessment of HER2 status in breast cancer reflects, at least in part, the wide variation in methodology, instrumentation, and experience of the laboratories performing the testing. The sensitivity and ...
The preoperative systemic inflammation response index (SIRI) independently predicts survival in postmenopausal women with breast cancer Xin Hua, Zhi-Qing Long, Xin Huang, Jia-Peng Deng, ... Huan-Xin Lin August 2020 Article 100560 select article Gut microbiota differences in Island Hispanic Puerto Ric...
Trends and current challenges of breast cancer in Tunisia: a retrospective study of 1262 cases with survival analysisdoi:10.1111/tbj.13062Belaid, ImtineneFatma, Leila BenEzzairi, FatenHochlaf, MakremChabchoub, ImeneGharbi, OlfaGahbiche, Salma...